Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →
ARTV · buys only · $1M+ · 36 trades
Trades
36
Buys 36 · Sells 0
People
6
Stocks
1
Disclosed value
$87.7M
range midpoints · Congress & executive
Filed late
0
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade